Aller au contenu principalAller à la recherche
Episciences
Revues en libre accès
|Connexion(nouvelle fenêtre)
French Academic Journal of Primary Care logo
French Academic Journal of Primary CareOpen access sister journal of exercer
French Academic Journal of Primary Care logo
French Academic Journal of Primary Care
|Connexion(nouvelle fenêtre)
Articles & volumes
Tous les articlesTous les volumesDernier volumeRubriquesAuteurs/Autrices
À propos
La revueActualités
Comités
Publier
Pour les auteurs/autricesCharte éthiquePour les relecteurs/relectrices
Submit
French Academic Journal of Primary Care logo
Notice de la revue
|
Contact
|
Crédits
eISSN 3130-334X
|
RSS
|
Atom
Episciences
Documentation
|
Remerciements
|
Politique de publication
Accessibilité : non conforme
|
Mentions légales
|
Déclaration de confidentialité
|
Termes d'utilisation
  1. Accueil > Articles & volumes >
  2. Articles >
  3. Incorporating ecolog ...
Article

Incorporating ecological data into a general practice prescribing guide: using the Hazard Score

Jade Monti (1), Audrey Olivier ORCID (1), Xavier Gocko ORCID (1), Quentin Ravoire (1)
(1) Université Jean Monnet - Faculté de Médecine Jacques Lisfranc
Télécharger l'article
Ouvrir sur HAL
Soumis le
March 27, 2025
Accepté le
February 15, 2026
Publié le
June 25, 2026
Modifié le
July 2, 2026
Volume 1
Volume 1 Juillet 2026
Recherche
DOI
10.46298/fajpc.18613
Licence
Attribution - Pas d'Utilisation Commerciale 4.0 International (CC BY-NC 4.0)
Indicateurs
149
Vues
107
Téléchargements

Incorporating ecological data into a general practice prescribing guide: using the Hazard Score

Jade Monti (1), Audrey Olivier ORCID (1), Xavier Gocko ORCID (1), Quentin Ravoire (1)
(1) Université Jean Monnet - Faculté de Médecine Jacques Lisfranc
Résumé
Introduction. In 2021, the French College of General Practice called on general practitioners to incorporate environmental considerations into their clinical practice. Objective. To incorporate environmental risk data for drugs listed in the 5th edition of the 'Guide to Therapeutics in General Medicine' published by the National College of General Practitioners, using the Hazard Score. Method. The environmental impact of the selected drugs was assessed using a Hazard Score ranging from 0 to 9, available through Janusinfo.se. Developed independently of pharmaceutical manufacturers this Swedish score incorporates three dimensions: environmental persistence, bioaccumulation in fatty tissues and toxicity to aquatic organisms. For drugs without an available Hazard Score, the ten most frequently prescribed drugs in France in 2023 were identified. A literature review was carried out to assign a rating ranging from A (low environmental impact) to C (high impact). Results. Six hundred and sixty-four drugs were included. A Hazard Score was assigned to 297 drugs (44.7%). The average Hazard Score was 3.15. Ninety-seven drugs (32.7%) had a Hazard Score of 0. Among the 367 drugs without a Hazard Score (55.3%), phloroglucinol was graded B. Codeine, prednisolone, alprazolam, oxazepam, amoxicillin and clavulanic acid, tramadol, and methadone were graded C. No grade was given to zopiclone and nefopam. Conclusion. This evaluation provides general practitioners with ecological risk data, facilitating environmentally conscious prescribing practices. Integrating such information into prescribing resources represents a crucial step towards sustainable medical practice.
Mots-clés
français
  • MESH: General Practitioners-Drugs-Environmental Pollution
  • [SDV]Life Sciences [q-bio]
  • [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
anglais
  • General Practitioners-Drugs-Environmental Pollution
Publications liées - jeux de données - logiciels
  • https://doi.org/10.46298/fajpc.18868
Aperçu
Loading PDF preview...
Références

  1. Myers S, Frumkin H. Global Health -Caring for Life to Care for Our Health. Paris: Rue de l'Échiquier, 2022.

  2. World Health Organization. World leaders and experts call for action to protect the environment from antimicrobial pollution. Geneva: WHO, 2022.

    DOI : 10.1596/38162

  3. Fuller R, Landrigan PJ, Balakrishnan K, et al. Pollution and health: a progress update. Lancet Planet Health 2022;6 (6):e535-47.

    DOI : 10.1016/s2542-5196(22)00090-0

  4. National Institute for Agricultural, Food and Environmen- tal Research. A first global study to assess the extent of pharmaceutical pollution in rivers. Paris: INRAE, 2022.

    DOI : 10.31926/but.fwiafe.2021.14.63.2.10

  5. Zuercher B. The impact of medicines on the environment. Rev Med Suisse 2022;7902:1471-3.

    DOI : 10.53738/revmed.2022.18.790-2.1471

  6. College of General Practice. Declaration calling on gen- eral practitioners worldwide to take action in support of glob- al health. Paris: CMG, 2019.

    DOI : 10.31128/ajgp-05-19-4932

  7. College of General Practice. Global health in general practice -Time for action. Paris: CMG, 2021.

    DOI : 10.1177/17557380241229967

  8. Dupont B, Faure S. The Hazard Score: a tool for reducing the environmental impact of prescriptions. Actualités Phar- maceutiques 2020;594(59):27-32.

    DOI : 10.1016/j.actpha.2020.01.009

  9. National Institute of Statistics and Economic Studies. France: A Social Portrait. 2023 Edition. Health Expenditure. Paris: INSEE, 2023.

    DOI : 10.1093/fs/kny102

  10. Ramström H, Martini S, Borgendahl J et al. Pharmaceu- ticals and Environment: a web-based decision support tool for considering the environmental aspects of medicines in use. Eur J Clin Pharmacol 2020;76:1151-1160.

    DOI : 10.1007/s00228-020-02885-1

  11. Perdrix C, Imbert P. 5th edition of Therapeutics in General Practice. Paris: CNGE, 2023.

    DOI : 10.2105/9780875533223appz

  12. Janusinfo. Pharmaceuticals and the environment. 2022. Available at: https://janusinfo.se/beslutsstod/ lakemedelochmiljo/ pharmaceuticalsandenviron- ment.

  13. Open Damir: comprehensive database on health insur- ance expenditure from 2009 to 2023. Paris: Assurance Mal- adie. 2024. Available at: https://www.assurance- maladie.ameli.fr/etudes-et-donnees/open-damir-depenses- sante-interregimes.

    DOI : 10.31219/osf.io/rc6an

  14. Davies B, Paul R, Osselton D, Woolley T. Analysis of raw effluent from two treatment works in South Wales for 35 new psychoactive substances, cocaine and cannabis. Sci REP 2024;14:20129.

    DOI : 10.1038/s41598-024-70378-7

  15. Wen-Jun S, Xiao-Bing L, Lei X, Chang-Er C, Guang- Ecological planning of the healthcare system. Paris: Minis- try of Health and Access to Healthcare, 2023.

  16. Ministry of the Economy, Finance and Industrial and Digital Sovereignty. Methodology for assessing the carbon footprint of medicines. Paris: Ministry of the Economy, Finance and Industrial and Digital Sovereignty, 2025.

    DOI : 10.1016/j.frl.2025.108152

  17. Hafiani, EM, Pauchard, JC, Pons, S et al. Reducing the environmental impact of general anaesthesia. Paris: SFAR, 2022.

  18. The Shift Project. Decarbonising the pharmaceutical industry: final report -June 2025 [Internet]. Paris: The Shift Project; 2025.

    DOI : 10.2172/6638816

  19. Organisation for Economic Co-operation and Develop- ment (OECD). Management of household pharmaceutical waste: limiting the environmental impact of unused or ex- pired medicines. Paris: OECD, 2022 CMR. Occurrence of micropollutants in surface waters: Monitoring of the Portuguese Lima and Douro river estuar- ies and the interconnected north-west coast. Mar Pollut Bull 2024;209:117140.

    DOI : 10.1016/j.marpolbul.2024.117140

  20. Verovšek T, Šuštarič A, Laimou-Geraniou M, et al. Re- moval of residues of psychoactive substances during wastewater treatment, their occurrence in receiving river waters and environmental risk assessment. Sci Total Envi- ron 2023;866:161257.

    DOI : 10.1016/j.scitotenv.2022.161257

  21. Stockholm County Council. Environmentally classified pharmaceuticals. SCC: Stockholm, 2012.

    DOI : 10.6027/9789289329453-4-en

  22. European Medicines Agency. Committee for Medicinal Products for Human Use. Guideline on the environmental risk assessment of medicinal products for human use. EMA: London, 2006.

    DOI : 10.1002/9780470748114.app3